These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35242229)

  • 41. Abnormal cervical cytology amongst women infected with human immunodeficiency virus in Limpopo province, South Africa.
    Ntuli ST; Maimela E; Skaal L; Mogale M; Lekota P
    Afr J Prim Health Care Fam Med; 2020 Oct; 12(1):e1-e4. PubMed ID: 33054270
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An assessment of care provided by a public sector STD clinic in Cape Town.
    Mathews C; van Rensburg A; Schierhout G; Coetzee N; Lombard CJ; Fehler HG; Ballard RC
    Int J STD AIDS; 1998 Nov; 9(11):689-94. PubMed ID: 9863583
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cervical cancer risk and impact of Pap-based screening in HIV-positive women on antiretroviral therapy in Johannesburg, South Africa.
    Rohner E; Sengayi M; Goeieman B; Michelow P; Firnhaber C; Maskew M; Bohlius J
    Int J Cancer; 2017 Aug; 141(3):488-496. PubMed ID: 28440019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular Identification of Cervical Microbes in HIV-Negative and HIV-Positive Women in an African Setting Using a Customized Bacterial Vaginosis Microbial DNA Quantitative PCR (qPCR) Array.
    Taku O; Onywera H; Mbulawa ZZA; Businge CB; Meiring TL; Williamson AL
    Microbiol Spectr; 2022 Jun; 10(3):e0222921. PubMed ID: 35647888
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Using national laboratory data to assess cumulative frequency of linkage after transfer to community-based HIV clinics in South Africa.
    Bassett IV; Huang M; Cloete C; Candy S; Giddy J; Frank SC; Freedberg KA; Losina E; Walensky RP; Parker RA
    J Int AIDS Soc; 2019 Jun; 22(6):e25326. PubMed ID: 31243898
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Utilization of cervical cancer screening and its associated factors among women of child-bearing age in Mangochi district, Malawi: a facility-based cross-sectional study.
    Mpachika-Mfipa F; Kululanga LI; Mfipa D; Kazembe A
    BMC Womens Health; 2023 Jun; 23(1):334. PubMed ID: 37355588
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Syphilis screening coverage and positivity by HIV treatment status among South African pregnant women enrolled in the 2019 antenatal HIV sentinel survey.
    Kufa T; Woldesenbet S; Cheyip M; Ayalew K; Kularatne R; Manda S; Lombard C; Puren A
    Sci Rep; 2023 Apr; 13(1):5322. PubMed ID: 37005466
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An audit of adherence to cervical cancer screening guidelines in a tertiary-level HIV clinic.
    Bolon J; Samson A; Irwin N; Murray L; Mbodi L; Stacey S; Aikman N; Moonsamy L; Zamparini J
    South Afr J HIV Med; 2023; 24(1):1490. PubMed ID: 37293604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distribution of Human Papillomavirus Genotypes among HIV-Positive and HIV-Negative Women in Cape Town, South Africa.
    McDonald AC; Tergas AI; Kuhn L; Denny L; Wright TC
    Front Oncol; 2014; 4():48. PubMed ID: 24672770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent HIV infection among pregnant women in the 2017 antenatal sentinel cross-sectional survey, South Africa: Assay-based incidence measurement.
    Woldesenbet S; Kufa-Chakezha T; Lombard C; Manda S; Cheyip M; Ayalew K; Chirombo B; Barron P; Diallo K; Parekh B; Puren A
    PLoS One; 2021; 16(4):e0249953. PubMed ID: 33852629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Awareness of HIV-positive status and linkage to treatment prior to pregnancy in the "test and treat" era: A national antenatal sentinel survey, 2017, South Africa.
    Woldesenbet S; Kufa T; Cheyip M; Ayalew K; Lombard C; Manda S; Nadol P; Barron P; Chirombo B; Igumbor E; Pillay Y; Puren A
    PLoS One; 2020; 15(3):e0229874. PubMed ID: 32168356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unique human papillomavirus-type distribution in South African women with invasive cervical cancer and the effect of human immunodeficiency virus infection.
    van Aardt MC; Dreyer G; Pienaar HF; Karlsen F; Hovland S; Richter KL; Becker P
    Int J Gynecol Cancer; 2015 Jun; 25(5):919-25. PubMed ID: 25950128
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda.
    Nakigozi H; Ndejjo R; Bazeyo W; Nabaggala A; Achola C; Iga M; Kalyesubula S; Kanamwangi B; Mutungi G; Batte C; Mukunya D; Sserwanga L; Gemageine G; Oyoo CA; Nabadda S
    BMC Cancer; 2024 Feb; 24(1):243. PubMed ID: 38383366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HPV types 16/18 L1 E6 and E7 proteins seropositivity and cervical cancer risk in HIV-positive and HIV-negative black South African women.
    Singini MG; Singh E; Bradshaw D; Chen WC; Motlhale M; Kamiza AB; de Villiers CB; Muchengeti M; Mathew CG; Newton R; Bender N; Waterboer T; Sitas F
    Infect Agent Cancer; 2022 Mar; 17(1):14. PubMed ID: 35351184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study.
    Jassat W; Cohen C; Tempia S; Masha M; Goldstein S; Kufa T; Murangandi P; Savulescu D; Walaza S; Bam JL; Davies MA; Prozesky HW; Naude J; Mnguni AT; Lawrence CA; Mathema HT; Zamparini J; Black J; Mehta R; Parker A; Chikobvu P; Dawood H; Muvhango N; Strydom R; Adelekan T; Mdlovu B; Moodley N; Namavhandu EL; Rheeder P; Venturas J; Magula N; Blumberg L;
    Lancet HIV; 2021 Sep; 8(9):e554-e567. PubMed ID: 34363789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increasing HIV prevalence in a rural district of South Africa from 1992 through 1995.
    Coleman RL; Wilkinson D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Sep; 16(1):50-3. PubMed ID: 9377125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
    Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
    PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trends in cervical cancer mortality in South Africa.
    Bailie RS; Selvey CE; Bourne D; Bradshaw D
    Int J Epidemiol; 1996 Jun; 25(3):488-93. PubMed ID: 8671548
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial.
    Thomas R; Burger R; Harper A; Kanema S; Mwenge L; Vanqa N; Bell-Mandla N; Smith PC; Floyd S; Bock P; Ayles H; Beyers N; Donnell D; Fidler S; Hayes R; Hauck K;
    Lancet Glob Health; 2017 Nov; 5(11):e1133-e1141. PubMed ID: 28964756
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High risk exposure to HIV among sexually active individuals who tested negative on rapid HIV Tests in the Tshwane District of South Africa-The importance of behavioural prevention measures.
    Mayaphi SH; Martin DJ; Olorunju SAS; Williams BG; Quinn TC; Stoltz AC
    PLoS One; 2018; 13(2):e0192357. PubMed ID: 29394288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.